About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Updates for mCRC
Treatment Updates for mCRC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
N
Tumor Agnostic Treatments in GI Cancers: Liquid Bipsy, Biomarkers
By
ecancer
FEATURING
Nicola Normanno
,
Katja Schmitz
By
ecancer
FEATURING
Nicola Normanno
,
Katja Schmitz
10 views
April 13, 2022
0 Comments
Login to view comments.
Click here to Login
Treatment Updates for mCRC
15:07
UCSF School of Medicine
Impact of Primary Tumor Location on OS and PFS in Patients with mCRC…
Feat.
A. Venook
16:00
ecancer
Tumor Agnostic Treatments in GI Cancers: Liquid Bipsy, Biomarkers
Feat.
N. Normanno,
K. Schmitz
11:42
Penn Medicine Abramson Cancer Center
Penn Medicine Updates on the Role of Systemic Therapy in CRC Liver M…
Feat.
T. Karasic
30:15
Houston Methodist Hospital
Role of Systemic Therapy in Colorectal Cancer
Feat.
M. O. Khalil
27:45
CECOG Academy
Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patien…
Feat.
G. Prager
41:57
2022 Community Oncology Conference
The Colorectal Cancer Epidemic: Root Causes & Remedies
Feat.
R. Goldberg
09:32
Michael Hummel
BRAF Testing in Metastatic Colorectal Carcinoma and Novel, Chemother…
11:34
ASCO 2022 Conference Coverage
ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment …
Feat.
C. Cremolini
34
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as …
Feat.
C. Cremolini
10:29
ASCO 2022 Conference Coverage
ASCO 2022 Using cfDNA to Identify Guideline-Relevant Biomarkers for …
Feat.
P. Kasi
18:02
Nebraska Oncology Society
ASCO 2022 Updates on RAS/BRAF/KRAS/NRAS Wild-Type mCRC: Summary of R…
Feat.
G. Kim
09:14
Nebraska Oncology Society
ASCO 2022 Updates on Colon Cancer Treatment
Feat.
G. Kim
02:15
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA An…
Feat.
J. Tie
07:56
ASCO 2022 Conference Coverage
ASCO 2022 on RAS Co-Mutation and Early Onset Disease Represent an Ag…
Feat.
B. Johnson
13:16
ESMO 2022 Conference Coverage
ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibi…
Feat.
M. Chalabi
29:47
Fortunato Ciardiello
Treatment Sequencing in mCRC
13:02
Yale Cancer Center
Personalized Treatment for Patients Living With mCRC
Feat.
M. Cecchini
